Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHRONIC LYMPHOCYTIC B-LEUKEMIA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04450069
What this trial is testing

CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell LymphomasDiffuse Large B Cell Lymphoma (DLBCL)Follicular Lymphoma (FL)+9 more
Calibr, a division of Scripps Research 18
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Looking for participantsNCT04186520
What this trial is testing

CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies

Who this might be right for
Non Hodgkin Lymphoma (NHL)Mantle Cell Lymphoma (MCL)Chronic Lymphocytic Leukemia (CLL)+5 more
Medical College of Wisconsin 100
Testing effectiveness (Phase 2)Ended earlyNCT02034227
What this trial is testing

Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChronic Lymphocytic Leukemia
Spirogen 6
Large-scale testing (Phase 3)WithdrawnNCT06205290
What this trial is testing

Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Large-scale testing (Phase 3)Study completedNCT00003341
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Who this might be right for
AnemiaLeukemiaLymphoma+1 more
Memorial Sloan Kettering Cancer Center 275
Not applicableStudy completedNCT06782854
What this trial is testing

Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaMarginal Zone Lymphoma(MZL)+5 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 102
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Very early researchUnknownNCT05739227
What this trial is testing

Safety and Efficacy of Allogenic CD19-CAR-NK Cells in Treatmenting r/r B-cell Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB-cell LymphomaChronic Lymphocytic Leukemia
Xuzhou Medical University 12
Testing effectiveness (Phase 2)Looking for participantsNCT04935684
What this trial is testing

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative Syndrome+4 more
University Hospital, Clermont-Ferrand 150
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Early research (Phase 1)Ended earlyNCT00234481
What this trial is testing

Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Exelixis
Early research (Phase 1)UnknownNCT00023816
What this trial is testing

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT03513562
What this trial is testing

Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations

Who this might be right for
Chronic Lymphocytic LeukemiaIbrutinib Resistance
Ohio State University Comprehensive Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT00012298
What this trial is testing

Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+6 more
National Cancer Institute (NCI) 81
Not applicableLooking for participantsNCT00923507
What this trial is testing

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

Who this might be right for
Waldenstrom MacroglobulinemiaLymphoplasmacytic LymphomaMonoclonal B-Cell Lymphocytosis+2 more
National Heart, Lung, and Blood Institute (NHLBI) 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04965493
What this trial is testing

A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Loxo Oncology, Inc. 600
Testing effectiveness (Phase 2)Looking for participantsNCT03986034
What this trial is testing

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 75
Not applicableStudy completedNCT04172467
What this trial is testing

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

Who this might be right for
Secondary Immunodeficiencies (SID)
AIO-Studien-gGmbH 1,086
Large-scale testing (Phase 3)Active Not RecruitingNCT04075292
What this trial is testing

Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Untreated Chronic Lymphocytic Leukemia
AstraZeneca 155
Next Page